Biotech Values

[acgood]

DEB025 is so different from other HCV drug candidates that we should expect the data reporting to deviate from the standard industry metrics to some degree

That may be the case...I have no idea. But that language is the sort of slippery slope to false claims and excuses that we would criticize other companies for deploying.